期刊文献+

耐亚胺培南铜绿假单胞菌医院感染危险因素分析 被引量:6

Risk factors of nosocomial infections caused by imipenem-resistant pseudomonas aeruginosa
原文传递
导出
摘要 目的分析耐亚胺培南铜绿假单胞菌(IRPA)产生的危险因素。方法收集医院2004年1月-2010年10月IRPA引起的56例医院感染患者的病历资料(IRPA组),对照组为62例医院感染敏感铜绿假单胞菌患者(敏感组),均按常规方法对进行分离培养和鉴定,采用纸片扩散(K-B)法进行药敏试验;IRPA组与敏感组之间比较计数资料采用t检验、χ2检验及多因素logistic回归进行分析。结果 t检验、χ2检验结果提示,年龄、混合感染、机械通气、患有慢性阻塞性肺疾病(COPD)、用过亚胺培南/美罗培南为IRPA医院感染相关因素;多因素logistic回归分析结果表明,机械通气,OR值为10.13及用过亚胺培南/美罗培南,OR值为36.68,为IRPA医院感染独立危险因素。结论机械通气以及亚胺培南/美罗培南的使用是IRPA医院感染的危险因素。 OBJECTIVE To investigate the risk factors for imipenem resistant Pseudomonas aeruginosa(IRPA) infections.METHODS A total of 56 cases of IRPA nosocomial infections were analyzed from Jan,2004 to Oct,2010 in Xiaogan central hospital.62 cases of antibiotic-sensitive P.aeruginosa infection were enrolled as control.Chi-square test and student t test and logistic regression analysis were used for statistics.RESULTS The factors associated with the development of IRPA nosocomial infection were age,co-infection,mechanical ventilation,COPD,fluoroquinolone and imipenem/meropenem use.Multivariate logistic regression analysis identified two independent factors: mechanical ventilation and previous imipenem/meropenem use.CONCLUSION Mechanical ventilation and previous imipenem/meropenem are the independent risk factors for IRPA infection.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第11期2212-2213,共2页 Chinese Journal of Nosocomiology
关键词 耐亚胺培南铜绿假单胞菌 医院感染 危险因素 IRPA Nosocomial infection Risk factor
  • 相关文献

参考文献9

二级参考文献44

共引文献1318

同被引文献48

  • 1彭少华,金正江,罗兰,李从荣.耐亚胺培南铜绿假单胞菌致医院感染危险因素的病例对照研究[J].中华流行病学杂志,2005,26(7):511-514. 被引量:17
  • 2王鹏远,孙立颖,赵敏,王东信,万远廉,刘玉村.外科患者耐美罗培南铜绿假单胞菌感染的危险因素分析[J].中华普通外科杂志,2006,21(7):484-487. 被引量:6
  • 3王贺,徐英春,陈民钧.细菌质粒介导的喹诺酮类抗菌药物耐药机制研究进展[J].中华医院感染学杂志,2007,17(5):618-620. 被引量:151
  • 4崔扬文,胡必杰,高晓东,等.2009年上海市医院感染现患率调查结果分析[J]. 中华医院感染学杂志,2011,21(11):2192-2195.
  • 5Zarb P, Coignard B, Griskeviciene J,et al.The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcareassociated infections and antimicrobial use[J]. Euro Surveill,2012,17(46):1-16.
  • 6胡阳敏.我院2002—2006年头孢菌素类药物应用分析[J].中国药业,2008,17(1):42-43. 被引量:8
  • 7JIANG Meijie, SUN qiying, LIU Guangli. Resistance analysis of Pseudomonas aeruginosa in 2006-2010[J]. Chin J Hosp In- fect, 2012, 22(8): 1703-1704.
  • 8CHEN Junqing, CHEN Danxia, HUANG Chengang, et al. Resist- ant to imipenem in Pseudomonas aeruginosa nosocomial infection risk factors analysis[J]. Chin J Hosp Infect, 2011, 21(11) : 2212-2213.
  • 9Clinical and Laboratory Standards Institute. National Commit- tee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing[S]. Pennsylvania: NC- CLS, 2011.
  • 10Maraki S, Mavros MN, Kofteridis DP, et at. Epidemiology and antimicrobial sensitivities of 536 multi-drug-resistant gram- negative bacilli isolated from patients treated on surgical wards[J]. Surg Infect(Larchmt), 2012, 13(5): 326-331.

引证文献6

二级引证文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部